On the other hand, YTHDF2 promotes the degradation of EGFR mRNA by directly binding to the m6A modification site at its 3′UTR to inhibit ERK/MAPK signaling pathway, thereby constraining cell proliferation and growth for HCC cells [94]. This evidence concerns the gene YTHDF2 and hepatocellular carcinoma.